Metraipolis › archive › dc_389e83da3a50
Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study — Europe PMC PMID:42421691
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42421691
- DOI
- 10.3389/fonc.2026.1846602
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T05:05:51.745Z
- SHA-256 of the archived text
b1339f302d200c21660d8a0b7e3f0200b29c65420ca5836f1acca4c6b6b63551- Stable URL of this page
https://metraipolis.com/documento/dc_389e83da3a50
How to cite
Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study — Europe PMC PMID:42421691 — Europe PMC (en), https://europepmc.org/article/MED/42421691 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_389e83da3a50 (Metraipolis archive dc_389e83da3a50, sha256 b1339f302d200c21660d8a0b7e3f0200b29c65420ca5836f1acca4c6b6b63551)
BibTeX
@misc{dc389e83da3a50,
title = {Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study — Europe PMC PMID:42421691},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42421691},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_389e83da3a50; sha256 b1339f302d200c21660d8a0b7e3f0200b29c65420ca5836f1acca4c6b6b63551},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42421691. Agents can read the archived copy with the MCP tool read_document.